Clinical Trials Search Results Display: Title Description with: Locations Eligibility Full Trial Description Custom ? Hide Search Criteria Show Search Criteria Drug: allogeneic multivirus-specific cytotoxic T lymphocytesFind trials that include: Any drugs shown Results 1-3 of 3 for your search: Start Over Select All on Page Sort by: Phase of Trial Title Type of Trial Status of Trial Age Range Trial ID Show 10 25 50 100 200 Results per Page 1. Donor Multi-virus-Specific Cytotoxic T Lymphocytes in Treating Epstein-Barr Virus, Cytomegalovirus, Adenovirus, Human Herpes Virus 6, and BK Virus Infections in Patients Who Have Undergone Donor Stem Cell Transplant Status: ActivePhase: Phase II, Phase IType: Biomarker/Laboratory analysis, Supportive careAge: Not specifiedTrial IDs: H-29966, NCI-2012-02979, ARMS, H-29966 ARMS, NCT01570283 2. Cytotoxic T Cells to Prevent Virus Infections Status: ActivePhase: Phase IType: TreatmentAge: Not specifiedTrial IDs: ACTCAT2, NCI-2015-01218, NCT01923766 3. Donor Multivirus-Specific T-Cells in Treating Patients with Persistent or Recurrent Viral Infections after Donor Stem Cell Transplant Status: ActivePhase: No phase specifiedType: Biomarker/Laboratory analysis, TreatmentAge: Not specifiedTrial IDs: H-33903, NCI-2014-00896, CHARMS, NCT02108522 Select All on Page Start Over
